Approval · Notice of Compliance 8142 · 2006
GARDASIL: Notice of Compliance 8142
Issued July 10, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8142
- Date
- July 10, 2006
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| GARDASIL | 02283190 | Cancelled Post Market |
Medicinal ingredients
- RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 6 L1 PROTEIN 20 MCG per 0.5ML
- RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 16 L1 PROTEIN 40 MCG per 0.5ML
- RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 18 L1 PROTEIN 20 MCG per 0.5ML
- RECOMBINANT HUMAN PAPILLOMAVIRUS TYPE 11 L1 PROTEIN 40 MCG per 0.5ML